To assess which ZIKV non-structural protein (NS1, NS3, NS4B, NS5) is responsible for inhibit tumor cell growth, Li et al. [4] conducted an in vivo/in vitro experiment in 2019. The gene discussed is KRAS; the disease is neoplasm.